In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review

The CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai's new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.